Hims & Hers Health, Inc. (HIMS) Expands Global Footprint With Eucalyptus Acquisition

Hims & Hers Health, Inc. (NYSE:HIMS) is among the 7 Oversold Pharma Stocks to Buy Now. Hims & Hers Health, Inc. (HIMS) Expands Global Footprint With Eucalyptus Acquisition Hims & Hers Health, Inc. (NYSE:HIMS) is one of the most oversold stocks. HIMS declared on February 19, 2026, that it has finalized a deal to purchase Eucalyptus for a maximum of $1.15 billion, subject to usual adjustments. The remaining consideration will consist of guaranteed deferred payments over the next 18 months and subsequent e ...